A Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan CEP of the European Pharmacopoeia monograph is often referred to as a Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan Certificate of Suitability (COS). The purpose of a Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan to their clients by showing that a Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan CEP has been issued for it. The manufacturer submits a Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan CEP (COS) as part of the market authorization procedure, and it takes on the role of a Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan CEP holder for the record. Additionally, the data presented in the Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan DMF.
A Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan suppliers with CEP (COS) on PharmaCompass.